Theracryf Plc (AIM:TCF)
London · Delayed Price · Currency is GBP · Price in GBX 0.2300
-0.0050 (-2.13%)
Jun 16, 2026, 9:41 AM GMT
Theracryf Market Cap
Theracryf has a market cap or net worth of 5.05 million as of June 16, 2026. Its market cap has decreased by -10.52% in one year.
Market Cap
5.05M
Enterprise Value
1.55M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.23
Market Cap Chart
Since October 21, 2015, Theracryf's market cap has decreased from 25.60M to 5.05M, a decrease of -80.27%. That is a compound annual growth rate of -14.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 15, 2026 | 5.05M | 17.50% |
| Dec 31, 2025 | 4.30M | 90.55% |
| Dec 31, 2024 | 2.26M | -48.72% |
| Dec 29, 2023 | 4.40M | -64.04% |
| Dec 30, 2022 | 12.23M | -13.59% |
| Dec 31, 2021 | 14.16M | -0.45% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Fusion Antibodies | 15.00M |
| Cizzle Biotechnology Holdings | 12.54M |
| Genflow Biosciences | 12.04M |
| Oxford BioDynamics | 7.72M |
| OptiBiotix Health | 6.40M |
| CRISM Therapeutics | 5.69M |
| Nuformix | 5.27M |
| Thalia Therapeutics | 4.79M |